CN111466558A - Energy glue suitable for long-distance running crowd and preparation method thereof - Google Patents
Energy glue suitable for long-distance running crowd and preparation method thereof Download PDFInfo
- Publication number
- CN111466558A CN111466558A CN201911326266.4A CN201911326266A CN111466558A CN 111466558 A CN111466558 A CN 111466558A CN 201911326266 A CN201911326266 A CN 201911326266A CN 111466558 A CN111466558 A CN 111466558A
- Authority
- CN
- China
- Prior art keywords
- energy
- weight portion
- weight portions
- gum
- sweetener
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003292 glue Substances 0.000 title claims abstract description 6
- 238000002360 preparation method Methods 0.000 title abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 29
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 15
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 15
- 229920000858 Cyclodextrin Polymers 0.000 claims abstract description 14
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims abstract description 14
- 235000003599 food sweetener Nutrition 0.000 claims abstract description 13
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 13
- 239000011707 mineral Substances 0.000 claims abstract description 13
- 239000003765 sweetening agent Substances 0.000 claims abstract description 13
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims abstract description 11
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims abstract description 11
- 239000006188 syrup Substances 0.000 claims abstract description 11
- 235000020357 syrup Nutrition 0.000 claims abstract description 11
- 235000013305 food Nutrition 0.000 claims abstract description 10
- 239000008213 purified water Substances 0.000 claims abstract description 9
- 239000000084 colloidal system Substances 0.000 claims abstract description 7
- XPYBSIWDXQFNMH-UYFOZJQFSA-N keto-D-fructose 1,6-bisphosphate Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)COP(O)(O)=O XPYBSIWDXQFNMH-UYFOZJQFSA-N 0.000 claims abstract description 7
- 150000003839 salts Chemical class 0.000 claims abstract description 7
- 235000000346 sugar Nutrition 0.000 claims description 21
- 238000003756 stirring Methods 0.000 claims description 20
- 239000000243 solution Substances 0.000 claims description 16
- 239000008367 deionised water Substances 0.000 claims description 12
- 229910021641 deionized water Inorganic materials 0.000 claims description 12
- 235000010755 mineral Nutrition 0.000 claims description 12
- 235000002639 sodium chloride Nutrition 0.000 claims description 10
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 9
- 241000180649 Panax notoginseng Species 0.000 claims description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 9
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 8
- 238000009835 boiling Methods 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- 238000005303 weighing Methods 0.000 claims description 8
- 239000000126 substance Substances 0.000 claims description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 6
- 239000005715 Fructose Substances 0.000 claims description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- 238000004140 cleaning Methods 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 230000033001 locomotion Effects 0.000 claims description 6
- 238000003860 storage Methods 0.000 claims description 5
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 4
- 239000001177 diphosphate Substances 0.000 claims description 4
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 claims description 4
- 235000011180 diphosphates Nutrition 0.000 claims description 4
- 239000000284 extract Substances 0.000 claims description 4
- 238000011049 filling Methods 0.000 claims description 4
- 238000010438 heat treatment Methods 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 239000011268 mixed slurry Substances 0.000 claims description 4
- 239000001103 potassium chloride Substances 0.000 claims description 4
- 235000011164 potassium chloride Nutrition 0.000 claims description 4
- 238000005086 pumping Methods 0.000 claims description 4
- 239000011780 sodium chloride Substances 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 4
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 claims description 3
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 claims description 3
- 108010011485 Aspartame Proteins 0.000 claims description 3
- 229920002148 Gellan gum Polymers 0.000 claims description 3
- 239000004376 Sucralose Substances 0.000 claims description 3
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 3
- 235000010323 ascorbic acid Nutrition 0.000 claims description 3
- 239000011668 ascorbic acid Substances 0.000 claims description 3
- 229960005070 ascorbic acid Drugs 0.000 claims description 3
- 239000000605 aspartame Substances 0.000 claims description 3
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 3
- 235000010357 aspartame Nutrition 0.000 claims description 3
- 229960003438 aspartame Drugs 0.000 claims description 3
- 235000010418 carrageenan Nutrition 0.000 claims description 3
- 239000000679 carrageenan Substances 0.000 claims description 3
- 229920001525 carrageenan Polymers 0.000 claims description 3
- 229940113118 carrageenan Drugs 0.000 claims description 3
- 235000015165 citric acid Nutrition 0.000 claims description 3
- 235000010492 gellan gum Nutrition 0.000 claims description 3
- 239000000216 gellan gum Substances 0.000 claims description 3
- 239000001630 malic acid Substances 0.000 claims description 3
- 235000011090 malic acid Nutrition 0.000 claims description 3
- 235000019408 sucralose Nutrition 0.000 claims description 3
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 3
- 229920001285 xanthan gum Polymers 0.000 claims description 3
- 239000000230 xanthan gum Substances 0.000 claims description 3
- 235000010493 xanthan gum Nutrition 0.000 claims description 3
- 229940082509 xanthan gum Drugs 0.000 claims description 3
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 3
- 244000247812 Amorphophallus rivieri Species 0.000 claims description 2
- 235000001206 Amorphophallus rivieri Nutrition 0.000 claims description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 2
- 229920002907 Guar gum Polymers 0.000 claims description 2
- 229920002752 Konjac Polymers 0.000 claims description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 claims description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
- 235000013312 flour Nutrition 0.000 claims description 2
- 239000000665 guar gum Substances 0.000 claims description 2
- 235000010417 guar gum Nutrition 0.000 claims description 2
- 229960002154 guar gum Drugs 0.000 claims description 2
- 239000000416 hydrocolloid Substances 0.000 claims description 2
- 239000000252 konjac Substances 0.000 claims description 2
- 235000010485 konjac Nutrition 0.000 claims description 2
- 229930189775 mogroside Natural products 0.000 claims description 2
- 239000001814 pectin Substances 0.000 claims description 2
- 229920001277 pectin Polymers 0.000 claims description 2
- 235000010987 pectin Nutrition 0.000 claims description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 2
- 235000019202 steviosides Nutrition 0.000 claims description 2
- 235000002906 tartaric acid Nutrition 0.000 claims description 2
- 239000011975 tartaric acid Substances 0.000 claims description 2
- 239000004383 Steviol glycoside Substances 0.000 claims 1
- 229930182488 steviol glycoside Natural products 0.000 claims 1
- 235000019411 steviol glycoside Nutrition 0.000 claims 1
- 150000008144 steviol glycosides Chemical class 0.000 claims 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 abstract description 20
- 210000004369 blood Anatomy 0.000 abstract description 16
- 239000008280 blood Substances 0.000 abstract description 16
- 239000004310 lactic acid Substances 0.000 abstract description 10
- 235000014655 lactic acid Nutrition 0.000 abstract description 10
- 230000004060 metabolic process Effects 0.000 abstract description 5
- 238000009776 industrial production Methods 0.000 abstract description 2
- 239000000499 gel Substances 0.000 description 27
- 230000000052 comparative effect Effects 0.000 description 14
- 230000003204 osmotic effect Effects 0.000 description 13
- 238000012360 testing method Methods 0.000 description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- 230000002829 reductive effect Effects 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 229920002527 Glycogen Polymers 0.000 description 3
- -1 cyclic polysaccharides Chemical class 0.000 description 3
- 229940096919 glycogen Drugs 0.000 description 3
- 229920001542 oligosaccharide Polymers 0.000 description 3
- 150000002482 oligosaccharides Chemical class 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 229930091371 Fructose Natural products 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 235000010358 acesulfame potassium Nutrition 0.000 description 2
- 239000000619 acesulfame-K Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 238000010411 cooking Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 230000009469 supplementation Effects 0.000 description 2
- 208000030090 Acute Disease Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000009759 San-Chi Substances 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 229960004998 acesulfame potassium Drugs 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- FYGDTMLNYKFZSV-DZOUCCHMSA-N alpha-D-Glcp-(1->4)-alpha-D-Glcp-(1->4)-D-Glcp Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-DZOUCCHMSA-N 0.000 description 1
- RNBGYGVWRKECFJ-ZXXMMSQZSA-N alpha-D-fructofuranose 1,6-bisphosphate Chemical compound O[C@H]1[C@H](O)[C@](O)(COP(O)(O)=O)O[C@@H]1COP(O)(O)=O RNBGYGVWRKECFJ-ZXXMMSQZSA-N 0.000 description 1
- WQZGKKKJIJFFOK-DVKNGEFBSA-N alpha-D-glucose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-DVKNGEFBSA-N 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000000386 athletic effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
- 229940107187 fructooligosaccharide Drugs 0.000 description 1
- 229940025237 fructose 1,6-diphosphate Drugs 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000002438 stress hormone Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The invention discloses an energy glue suitable for long-distance running crowd and a preparation method thereof, and the energy glue is characterized in that: comprises 10 to 30 weight portions of highly branched cyclodextrin, 10 to 30 weight portions of oligomeric maltose syrup, 0.5 to 3 weight portions of pseudo-ginseng, 2 to 5 weight portions of 1, 6-diphosphofructose, 0.1 to 0.5 weight portion of acidity regulator, 0.005 to 0.1 weight portion of sweetener, 0.05 to 0.5 weight portion of mineral salt, 0.01 to 0.2 weight portion of food essence, 0.05 to 0.5 weight portion of hydrophilic colloid and 20 to 60 weight portions of purified water. The energy gel disclosed by the invention is uncomplicated in formula, can effectively reduce the blood lactic acid level after exercise, promotes lactic acid metabolism, relieves exercise fatigue, is simple in preparation process, and is suitable for large-scale industrial production.
Description
Technical Field
The invention relates to the field of sports nourishment, in particular to an energy gel suitable for long-distance running sports people and a preparation method thereof.
Technical Field
Sugar supplementation is essential to improve and maintain the athletic ability of long-distance running program population. The high carbohydrate is supplemented in the movement, so that the stability of the blood sugar level can be effectively maintained, the stress hormone level can be further reduced, the adverse reaction of an immune system is relieved, and the occurrence of sports fatigue is delayed. Therefore, in the current research background and large sports environment, sugar supplementation in long-distance running is a research hotspot.
The energy gel is a gel food with high energy density and is a good energy source in the process of long-distance running. Energy gel food in the market is mainly imported from abroad, the raw material sources mainly focus on monosaccharide and oligosaccharide which are rapidly absorbed and utilized, the molecular weight is relatively small, long-time continuous energy supply cannot be guaranteed, the sweetness and osmotic pressure of the product are high, and a sporter can lose a large amount of water of cells in vivo after drinking the product, so that the cells are wrinkled. The energy gel is generally eaten by drinking a large amount of water, so that the gastrointestinal burden is caused and the taking mode is inconvenient. Therefore, the research and the demand for energy gel capable of overcoming the above disadvantages are more and more urgent.
Disclosure of Invention
The invention aims to provide an energy gel suitable for long-distance running crowds, aiming at overcoming the defects and shortcomings in the prior art, the energy gel is made to be close to the osmotic pressure of plasma (280-320 mosm/L) by adjusting the types and the using amounts of components in the energy gel, a large amount of water is not required to be additionally supplemented in the eating process, the energy gel is convenient to eat, the gastrointestinal burden is reduced, and secondly, the energy gel can improve the anoxia endurance of endurance projects athletes, achieves the purposes of resisting fatigue and prolonging the exercise time, and is beneficial to the continuation of high-level exercise performance.
In order to achieve the purpose, the invention adopts the following technical scheme:
the utility model provides an energy is glued suitable for long-distance running motion crowd uses which characterized in that: comprises 10 to 30 weight portions of highly branched cyclodextrin, 10 to 30 weight portions of oligomeric maltose syrup, 0.5 to 3 weight portions of pseudo-ginseng, 2 to 5 weight portions of 1, 6-diphosphofructose, 0.1 to 0.5 weight portion of acidity regulator, 0.005 to 0.1 weight portion of sweetener, 0.05 to 0.5 weight portion of mineral salt, 0.01 to 0.2 weight portion of food essence, 0.05 to 0.5 weight portion of hydrophilic colloid and 20 to 60 weight portions of purified water;
wherein the pseudo-ginseng needs to be prepared into an extracting solution in advance according to the following steps: cleaning Notoginseng radix, slicing, adding 10 times deionized water, extracting at 95 deg.C for 2 hr, adding 10 times deionized water, extracting at 95 deg.C for 1 hr, mixing extractive solutions, and filtering to obtain Notoginseng radix extractive solution.
Preferably, the energy gel comprises: 20-30 parts of highly branched cyclodextrin, 10-25 parts of oligomeric maltose syrup, 1-3 parts of pseudo-ginseng, 3-5 parts of 1, 6-diphosphofructose, 0.2-0.4 part of acidity regulator, 0.01-0.08 part of sweetener, 0.05-0.3 part of mineral salt, 0.03-0.1 part of food essence, 0.1-0.3 part of hydrophilic colloid and 30-55 parts of purified water.
The energy gel is characterized in that the acidity regulator is preferably made of one or more of citric acid, malic acid, tartaric acid and ascorbic acid.
The energy gum is characterized in that the sweetener is preferably prepared from one or more of sucralose, aspartame, acesulfame-K, stevioside and mogroside.
The energy glue is characterized in that the mineral salt is preferably one or more of common salt and potassium chloride.
The hydrocolloid mixture according to the invention is preferably a mixture of two or more of carrageenan, xanthan gum, konjac flour, gellan gum, pectin, guar gum, and sodium carboxymethylcellulose.
Another object of the present invention is to provide a method for preparing an energy gel suitable for long-distance running sports people, which has the advantages of simple operation steps, convenient control, high production efficiency and low production cost, and the method comprises the following steps:
(1) cleaning Notoginseng radix, slicing, adding 10 times of deionized water, extracting at 95 deg.C for 2 hr, adding 10 times of deionized water, extracting at 95 deg.C for 1 hr, mixing extractive solutions, and filtering while hot to obtain Notoginseng radix extractive solution;
(2) adding the formula amount of the pseudo-ginseng extract prepared in the step (1) into a sugar boiling tank, stirring and heating to 80-90 ℃, adding the formula amount of highly branched cyclodextrin, stirring until the highly branched cyclodextrin is completely dissolved, adding the formula amount of oligomeric maltose syrup, and uniformly stirring;
(3) uniformly mixing the hydrophilic colloid with the 1, 6-fructose diphosphate with the formula amount in advance, adding the mixture into the sugar boiling pot obtained in the step (2), uniformly stirring, and keeping the temperature at 90-95 ℃ for 10 min;
(4) weighing the acidity regulator, the sweetener and the mineral substances according to the formula amount, and dissolving the mixture in a proper amount of purified water for later use;
(5) putting the mixed materials in the sugar boiling pot into a flavoring tank, cooling to about 85 ℃, sequentially adding the acidity regulator, the sweetener and the mineral substance aqueous solution prepared in the step (4) under stirring, and continuously cooling to about 75 ℃, and adding the food essence according to the formula amount;
(6) adding a proper amount of water, fixing the volume to the required volume, pumping the mixed slurry into a storage tank, filling and sterilizing.
Advantageous effects
The energy gel disclosed by the invention is uncomplicated in formula, can effectively reduce the blood lactic acid level after exercise, promotes lactic acid metabolism, relieves exercise fatigue, is simple in preparation process, and is suitable for large-scale industrial production.
Detailed Description
Hereinafter, the present invention will be described in detail. Before the description is made, it should be understood that the terms used in the present specification and the appended claims should not be construed as limited to general and dictionary meanings, but interpreted based on the meanings and concepts corresponding to technical aspects of the present invention on the basis of the principle that the inventor is allowed to define terms appropriately for the best explanation. Accordingly, the description proposed herein is just a preferable example for the purpose of illustrations only, not intended to limit the scope of the invention, so it should be understood that other equivalents and modifications could be made thereto without departing from the spirit and scope of the invention.
Among the various components of the energy gel suitable for use by the long-run sports population according to the present invention, the Highly Branched Cyclodextrin (HBCD) is α -D-glucose monomers linked together by α -1, 4-glycosidic bonds and branched, cyclic polysaccharides occurring through α -1, 6-glycosidic bonds, which has the advantages of low osmotic pressure, high reactivity, and easy design of end-group functional groups.
Oligosaccharides are small molecule compounds that have a lower osmotic pressure than glucose at equivalent glucose levels, which contributes to the absorption rate and rapid absorption of water during exercise. The functional oligosaccharide in the food mainly comprises oligomeric maltose, fructo-oligosaccharide and the like; the absorption speed of the oligomeric maltose syrup is obviously higher than that of starch, and the insulin reaction caused by the extremely rapid rise of the blood sugar concentration after a large amount of absorption at one time is avoided while the energy is rapidly supplemented in the movement; the sugar-containing composition has the characteristics of low osmotic pressure, low sweetness and low calorie when the sugar concentration is higher, and is beneficial to the taste requirement of athletes in the process of sugar supplement and the rapid absorption of sugar on the small intestine wall.
Notoginseng is sweet in nature and taste, slightly bitter and warm, enters liver and stomach meridians, has the functions of removing blood stasis and stopping bleeding, and tonifying deficiency and strengthening. The product is rich in effective components of sanchinoside, sanchi polysaccharide, sanchinin and flavone, such as Rg1 and Re, and has effects of increasing animal coronary blood flow, reducing myocardial oxygen consumption, relieving exercise-induced fatigue, increasing glycogen storage, reducing serum uric acid content after exercise, inhibiting blood lactic acid content increase after exercise, and reducing exercise-induced fatigue.
Fructose-1, 6-diphosphate is not a normal fructose, and is more different from glucose, glycogen or starch. Firstly, it can be used as a direct energy source substance for the body, so that the muscle can supplement more ATP in the movement; secondly, it is an intermediate product of glycolysis in cells, can reduce the dependence of cells on aerobic metabolism, directly regulate certain metabolism or directly participate in energy supply as a substrate, thereby shortening the sugar oxidation time and having higher speed of providing energy compared with the speed of directly oxidizing glucose or muscle glycogen; thirdly, the 1, 6-diphosphofructose can inhibit the generation of free radicals and protect the red blood cells of the body, thereby playing a positive role in preventing exercise-induced fatigue caused by anemia.
The following examples are given by way of illustration of embodiments of the invention and are not to be construed as limiting the invention, and it will be understood by those skilled in the art that modifications may be made without departing from the spirit and scope of the invention. Unless otherwise specified, reagents and equipment used in the following examples are commercially available products.
Example 1
Table 1: raw material batching table
The preparation method comprises the following steps:
(1) weighing 2.5kg of pseudo-ginseng, cleaning, slicing, putting into an extraction pot, adding 25kg of deionized water for the first time, extracting for 2 hours at 95 ℃, adding 25kg of deionized water for the second time, extracting for 1 hour at 95 ℃, combining the extracting solutions, and filtering while the extracting solutions are hot to obtain 50kg of pseudo-ginseng extracting solution;
(2) adding the pseudo-ginseng extract prepared in the step (1) into a sugar decocting tank, stirring and heating to 80-90 ℃, adding 21kg of highly branched cyclodextrin, stirring until the highly branched cyclodextrin is completely dissolved, adding 20kg of oligomeric maltose syrup, and uniformly stirring;
(3) weighing 0.06kg of xanthan gum, 0.06kg of gellan gum and 1.5kg of 1, 6-fructose diphosphate, uniformly mixing in advance, adding into a sugar cooking pot, uniformly stirring, and keeping the temperature at 90-95 ℃ for 10 min;
(4) weighing 0.2kg of citric acid, 0.01kg of sucralose, 0.1kg of potassium chloride and 0.17kg of sodium chloride, and dissolving in 5kg of purified water for later use;
(5) putting the mixed materials in the sugar boiling pot into a flavoring tank, adding the acidity regulator, the sweetener and the mineral substance aqueous solution in the step (4) under the stirring state when the temperature is reduced to about 85 ℃, and adding 0.1kg of passion fruit-flavored liquid essence when the temperature is continuously reduced to about 75 ℃;
(6) adding a proper amount of water, fixing the volume to the required volume, pumping the mixed slurry into a storage tank, filling and sterilizing.
Example 2
Table 2: raw material batching table
The preparation method comprises the following steps:
(1) weighing 2.5kg of pseudo-ginseng, cleaning, slicing, putting into an extraction pot, adding 25kg of deionized water for the first time, extracting for 2 hours at 95 ℃, adding 25kg of deionized water for the second time, extracting for 1 hour at 95 ℃, combining the extracting solutions, and filtering while the extracting solutions are hot to obtain 50kg of pseudo-ginseng extracting solution;
(2) adding the pseudo-ginseng extract prepared in the step (1) into a sugar decocting tank, stirring and heating to 80-90 ℃, adding 30kg of highly branched cyclodextrin, stirring until the highly branched cyclodextrin is completely dissolved, adding 10kg of oligomeric maltose syrup, and uniformly stirring;
(3) weighing 0.15kg of carrageenan and 3kg of 1, 6-fructose diphosphate, uniformly mixing in advance, adding the mixture into a sugar cooking pot, uniformly stirring, and keeping the temperature at 90-95 ℃ for 10 min;
(4) weighing 0.15kg of malic acid, 0.05 kg of ascorbic acid, 0.02kg of acesulfame potassium, 0.02kg of aspartame, 0.18kg of potassium chloride and 0.15kg of sodium chloride, and dissolving in 4kg of purified water for later use;
(5) putting the mixed materials in the sugar boiling pot into a flavoring tank, adding the acidity regulator, the sweetener and the mineral substance aqueous solution in the step (4) under the stirring state when the temperature is reduced to about 85 ℃, and adding 0.1kg of apple-flavored liquid essence when the temperature is continuously reduced to about 75 ℃;
(6) adding a proper amount of water, fixing the volume to the required volume, pumping the mixed slurry into a storage tank, filling and sterilizing.
Comparative example 1
An energy gum was prepared in the same manner as in example 1, except that the highly branched maltodextrin was not added, but the white granulated sugar was used instead, and the 1, 6-diphosphofructose was not added, but the crystalline fructose was used instead.
Comparative example 2
An energy gum was prepared in the same manner as in example 2, except that no malto-oligosaccharide syrup was added, and glucose was substituted.
Experimental example 1: energy gel osmotic pressure detection
1.1 test specimens
Energy gels prepared in example 1, example 2, comparative example 1 and comparative example 2.
1.2 test methods
The osmotic pressure of example 1, example 2, comparative example 1 and comparative example 2 were measured in this order.
1.3 test apparatus
FM-8P full-automatic freezing point osmometer of Shanghai medical instrument factory.
1.4 test results
TABLE 3 comparison of osmotic pressures of examples and comparative examples
Test sample | Osmotic pressure (mosm/L) |
Example 1 | 302 |
Example 2 | 318 |
Comparative example 1 | 1210 |
Comparative example 2 | 1380 |
As is clear from Table 3, the osmotic pressures of examples 1 and 2 are both similar to the plasma osmotic pressure (280 to 320 mosm/L), and the osmotic pressures of comparative examples 1 and 2 are both higher than the plasma osmotic pressure.
Experimental example 2: blood lactic acid content detection for middle and long distance runners
2.1 test specimens
Energy gels prepared in example 1 and comparative example 1.
2.2 test population
10 high-level male track and field runners at Beijing university of sports were selected as study subjects in this study, with the subjects having an average age of 21.6 + -0.69 years, a height of 175.7 + -4.21 cm and a weight of 52.6 + -7.41 kg. The exercise level is second grade or above of the state, the physical health condition is good, no history of acute and chronic diseases exists, and a certain special training background exists. The subjects had no intake of drugs such as alcohol and caffeine, no overnight stay, and no high-intensity exercise for one week before each experiment.
2.3 test apparatus
The blood lactic acid adopts YSI 1500SPORT L ACTATE ANA L YZER, and the method is enzyme electrode method, and the power bicycle adopts MONARK839E power bicycle.
2.4 Experimental procedures
The 10 subjects will have 2 sequential interventions with 1 week intervals between each phase with one of the two energy gels (example 1 energy gel, comparative example 1 energy gel) administered to each 5 subjects during each phase. In each stage, blood is drawn quietly and blood lactate index is measured, and then the maximum oxygen uptake is tested. Followed by a motion profile. The time period of index collection in each stage is a basic value, and the time period is immediately after exercise, 5min after exercise, 15min after exercise and 30min after exercise. All indices remained consistent at the acquisition time point. The administration time periods of the different energy gels in each stage are 30min before, 60min and 90min during exercise, and the dosage is 50g each time. During the 2-phase experiments, all subjects completed a long pedaling power cycling at each phase. The exercise mode is that the bicycle is pedaled for 90min on a power bicycle, and the exercise intensity is personal70%V02max, during which the rotation speed is maintained at 60 rpm/min.
2.5 results of the experiment
The blood lactic acid content of the subject at the basic value, immediately after exercise, 5min after exercise, 15min after exercise and 30min after exercise is respectively tested, and specific experimental data are shown in the following table.
TABLE 4 mean blood lactate concentration variation (mmol/L) (X + -SD) for subjects taking different energy gels
Test sample | Base value | Immediately after exercise | 5min after exercise | Exercising for 15min | 30min after exercise |
Example 1 | 3.81±0.83 | 4.58±0.88 | 4.43±1.22 | 4.24±1.03 | 4.36±0.73 |
Comparative example 1 | 4.26±0.77 | 6.45±0.93* | 7.03±0.89* | 7.79±1.24* | 6.93±0.64* |
Indicates that the difference is significant compared with the group of example 1
As can be seen from table 4, there was no significant difference between the blood lactate levels of the subjects in group 2 before exercise, and the blood lactate content was tested immediately after exercise, 5min after exercise, 15min after exercise, and 30min after exercise, respectively, and the mean blood lactate values of the subjects taking the energy gel according to example 1 of the present invention were found to be significantly lower than those of the subjects taking the energy gel according to comparative example 1. This shows that the administration of the energy gel according to example 1 of the present invention can lower the blood lactic acid level after exercise, promote lactic acid metabolism, and relieve exercise fatigue.
Claims (7)
1. The utility model provides an energy is glued suitable for long-distance running motion crowd uses which characterized in that: comprises 10 to 30 weight portions of highly branched cyclodextrin, 10 to 30 weight portions of oligomeric maltose syrup, 0.5 to 3 weight portions of pseudo-ginseng, 2 to 5 weight portions of 1, 6-diphosphofructose, 0.1 to 0.5 weight portion of acidity regulator, 0.005 to 0.1 weight portion of sweetener, 0.05 to 0.5 weight portion of mineral salt, 0.01 to 0.2 weight portion of food essence, 0.05 to 0.5 weight portion of hydrophilic colloid and 20 to 60 weight portions of purified water;
wherein the pseudo-ginseng needs to be prepared into an extracting solution in advance according to the following steps: cleaning Notoginseng radix, slicing, adding 10 times deionized water, extracting at 95 deg.C for 2 hr, adding 10 times deionized water, extracting at 95 deg.C for 1 hr, mixing extractive solutions, and filtering to obtain Notoginseng radix extractive solution.
2. The energy gel of claim 1, wherein the energy gel comprises: 20-30 parts of highly branched cyclodextrin, 10-25 parts of oligomeric maltose syrup, 1-3 parts of pseudo-ginseng, 3-5 parts of 1, 6-diphosphofructose, 0.2-0.4 part of acidity regulator, 0.01-0.08 part of sweetener, 0.05-0.3 part of mineral salt, 0.03-0.1 part of food essence, 0.1-0.3 part of hydrophilic colloid and 30-55 parts of purified water.
3. Energy gum according to claim 1 or 2, characterized in that the acidity regulator is made from one or more of citric acid, malic acid, tartaric acid and ascorbic acid.
4. The energy gum of claim 1 or 2, wherein the sweetener is selected from one or more of sucralose, aspartame, acesulfame k, steviol glycosides and mogrosides.
5. The energy gum of claim 1 or 2, wherein the mineral salt is preferably selected from one or more of common salt and potassium chloride.
6. The energy gum of claim 1 or 2, wherein the hydrocolloid mixture is selected from the group consisting of carrageenan, xanthan gum, konjac flour, gellan gum, pectin, guar gum, and sodium carboxymethylcellulose.
7. The method for preparing the energy glue according to any one of the claims 1 to 6, comprising the following steps:
(1) cleaning Notoginseng radix, slicing, adding 10 times of deionized water, extracting at 95 deg.C for 2 hr, adding 10 times of deionized water, extracting at 95 deg.C for 1 hr, mixing extractive solutions, and filtering while hot to obtain Notoginseng radix extractive solution;
(2) adding the formula amount of the pseudo-ginseng extract prepared in the step (1) into a sugar boiling tank, stirring and heating to 80-90 ℃, adding the formula amount of highly branched cyclodextrin, stirring until the highly branched cyclodextrin is completely dissolved, adding the formula amount of oligomeric maltose syrup, and uniformly stirring;
(3) uniformly mixing the hydrophilic colloid with the 1, 6-fructose diphosphate with the formula amount in advance, adding the mixture into the sugar boiling pot obtained in the step (2), uniformly stirring, and keeping the temperature at 90-95 ℃ for 10 min;
(4) weighing the acidity regulator, the sweetener and the mineral substances according to the formula amount, and dissolving the mixture in a proper amount of purified water for later use;
(5) putting the mixed materials in the sugar boiling pot into a flavoring tank, cooling to about 85 ℃, sequentially adding the acidity regulator, the sweetener and the mineral substance aqueous solution prepared in the step (4) under stirring, and continuously cooling to about 75 ℃, and adding the food essence according to the formula amount;
(6) adding a proper amount of water, fixing the volume to the required volume, pumping the mixed slurry into a storage tank, filling and sterilizing.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911326266.4A CN111466558A (en) | 2019-12-20 | 2019-12-20 | Energy glue suitable for long-distance running crowd and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911326266.4A CN111466558A (en) | 2019-12-20 | 2019-12-20 | Energy glue suitable for long-distance running crowd and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111466558A true CN111466558A (en) | 2020-07-31 |
Family
ID=71745010
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911326266.4A Pending CN111466558A (en) | 2019-12-20 | 2019-12-20 | Energy glue suitable for long-distance running crowd and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111466558A (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104159457A (en) * | 2012-03-09 | 2014-11-19 | 株式会社明治 | Food or beverage that allows high degree of absorption of water |
CN105962346A (en) * | 2016-06-03 | 2016-09-28 | 汤臣倍健股份有限公司 | Energy gel and deep processing preparation method thereof |
CN106509883A (en) * | 2016-12-29 | 2017-03-22 | 北京康比特体育科技股份有限公司 | Soft energy bars capable of rapidly supplementing energy and preparation method thereof |
CN106937743A (en) * | 2017-04-24 | 2017-07-11 | 诺和生物技术(天津)有限公司 | A kind of antisecosis agent and preparation method thereof |
WO2018146697A1 (en) * | 2017-02-08 | 2018-08-16 | Jolly Vadakkemuri Mathew | Optimized nutrient salt composition |
CN108606269A (en) * | 2018-04-12 | 2018-10-02 | 昆明邦宇制药有限公司 | A kind of sports type nutritional supplement and preparation method thereof |
-
2019
- 2019-12-20 CN CN201911326266.4A patent/CN111466558A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104159457A (en) * | 2012-03-09 | 2014-11-19 | 株式会社明治 | Food or beverage that allows high degree of absorption of water |
CN105962346A (en) * | 2016-06-03 | 2016-09-28 | 汤臣倍健股份有限公司 | Energy gel and deep processing preparation method thereof |
CN106509883A (en) * | 2016-12-29 | 2017-03-22 | 北京康比特体育科技股份有限公司 | Soft energy bars capable of rapidly supplementing energy and preparation method thereof |
WO2018146697A1 (en) * | 2017-02-08 | 2018-08-16 | Jolly Vadakkemuri Mathew | Optimized nutrient salt composition |
CN106937743A (en) * | 2017-04-24 | 2017-07-11 | 诺和生物技术(天津)有限公司 | A kind of antisecosis agent and preparation method thereof |
CN108606269A (en) * | 2018-04-12 | 2018-10-02 | 昆明邦宇制药有限公司 | A kind of sports type nutritional supplement and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
邹在平等: "超支化环糊精聚合物研究进展", 《高分子通报》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1328988C (en) | Sports drink | |
US7214667B2 (en) | Drugs against articular failure | |
CN106106971A (en) | A kind of Sugarless type jelly work containing milk calcium and preparation method thereof | |
CN111328904B (en) | Preparation method of functional jasmine tea beverage | |
CN106880058B (en) | Sugar-free syrup and preparation method thereof | |
CN103704808A (en) | Salt sports beverage and preparation technology thereof | |
CN115404252A (en) | Auricularia auricula polysaccharide and application and preparation method thereof | |
CN110960497B (en) | Hyaluronic acid buccal tablet and preparation method thereof | |
CN105639258A (en) | New edible sugar substitute sugar preparation | |
CN104757632A (en) | Fructose rosa roxburghii juice suspending beverage and production method thereof | |
CN103653113A (en) | Sea-buckthorn beverage | |
CN102511616A (en) | Low-energy candy containing natural ginseng and production method thereof | |
CN106509540A (en) | Drink for enhancing immunity and improving athletic ability | |
CN112841312A (en) | Collagen milk tea solid beverage and eating method thereof | |
CN105639619A (en) | Energy gel and preparation method thereof | |
CN112142868A (en) | Morchella polysaccharide extract, morchella polysaccharide buccal tablet and preparation method thereof | |
CN105255961A (en) | Isomerization method for glucose in fructose production process | |
CN103284261A (en) | Sports drink containing morinda officinalis and preparation method thereof | |
CN107955825A (en) | A kind of preparation method using D-Psicose as the sweetener composition of main component | |
CN111466558A (en) | Energy glue suitable for long-distance running crowd and preparation method thereof | |
CN111869878A (en) | Carbohydrate oral clear liquid with low 5-HMF content and preparation method thereof | |
Vasilescu et al. | Sweeteners and metabolic diseases: xylitol as a new player | |
CN107094969A (en) | Sweet osmanthus soft sweets rich in acteoside and rhodioside and preparation method thereof | |
CN107668723A (en) | A kind of plastic bottle L arabinose oral liquids easy to break and preparation method thereof | |
CN111671025B (en) | Sugar electrolyte beverage for relieving alcoholism and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200731 |